Search results
Results From The WOW.Com Content Network
The role of the endocannabinoid system (ECS) in female fertility has long been suspected and studied. [3] Most studies through 2013 linking development of the fetus and cannabis show effects of consumption during the gestational period, but abnormalities in the endocannabinoid system during the phase of placental development are also linked with problems in pregnancy. [4]
Nearly 70 percent of licensed Colo. dispensaries recommended that a pregnant woman use pot to help with nausea and morning sickness.
Attitudes toward marijuana in the U.S. are changing and, with them, so is the legal landscape — and questions about how all of these changes may impact teens and young adults.While marijuana use ...
Contraindications to breastfeeding are those conditions that could compromise the health of the infant if breast milk from their mother is consumed. Examples include galactosemia , untreated HIV , untreated active tuberculosis , Human T-lymphotropic virus 1 or II , uses illicit drugs , or mothers undergoing chemotherapy or radiation treatment .
Over time, the marijuana gateway hypothesis has been studied more and more. In one published study, the use of marijuana was shown not a reliable gateway cause of illicit drug use. [67] However, social factors and environment influence drug use and abuse, making the gateway effects of cannabis different for those in differing social circumstances.
For premium support please call: 800-290-4726 more ways to reach us
Acute effects while under the influence can sometimes include euphoria or anxiety. [ 4 ] [ 5 ] Although some assert that cannabidiol (CBD), another cannabinoid found in cannabis in varying amounts, may alleviate the adverse effects of THC that some users experience, [ 6 ] little is known about CBD's effects on humans.
While marijuana has been decriminalized throughout many states in the US, it remains a Schedule I drug as of October 2024. However, on January 12, 2024, the FDA announced its recommendation that marijuana be moved to a Schedule III drug, which is a much less strictly-regulated category and would acknowledge its potential for medical use. [67]